Results 131 to 140 of about 235,874 (246)

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.

open access: yesBlood, 2013
E. Rego   +29 more
semanticscholar   +1 more source

Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemia. [PDF]

open access: yesHematol Transfus Cell Ther
Moraes CRP   +6 more
europepmc   +1 more source

Long‐term follow‐up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients

open access: yesAmerican journal of hematology/oncology, 2013
L. Adès   +20 more
semanticscholar   +1 more source

C010 | INVESTIGATING DISTINCT FEATURES OF PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) REQUIRING TREATMENT ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODIES: A SUB-ANALYSIS OF THE ITALIAN ITP REGISTRY (GIMEMA ITP0918)

open access: yesHaematologica
Introduction. The clinical significance of positive antiphospholipid antibodies (aPL) in patients with primary immune thrombocytopenia (pITP) remains uncertain. To address this gap, we have compared the clinical characteristics of pITP patients with and
B. Clerici   +46 more
doaj  

Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia. [PDF]

open access: yesJ Transl Med
Dutta D   +18 more
europepmc   +1 more source

Acute Promyelocytic Leukemia with double minute chromosomes: a rare case with high relapse risk. [PDF]

open access: yesOxf Med Case Reports
Sasaki Y   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy